Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development

International Journal of Molecular Medicine

Volumn 3, Issue 6, 1999, Pages 585-589

  Katarinaejeska R ^a   Sjöberg, Rose Marie ^b   Kogner, Per ^a   Martinsson, Tommy ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Neuroblastoma; P73 cxpression; RT PCR

Indexed keywords

DNA BINDING PROTEIN; NUCLEAR PROTEIN; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; BIOSYNTHESIS; CANCER STAGING; CHROMOSOME 1; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MUTATION; NERVOUS SYSTEM TUMOR; NEUROBLASTOMA; ONCOGENE MYC; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 1; DNA-BINDING PROTEINS; EXONS; GENE AMPLIFICATION; GENE EXPRESSION; GENES, MYC; GENES, TUMOR SUPPRESSOR; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MUTATION; NEOPLASM STAGING; NERVOUS SYSTEM NEOPLASMS; NEUROBLASTOMA; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE DELETION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0033144972     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Brodeur GM: Clinical and biological aspects of neuroblastoma. In: The Genetic Basis of Human Cancer. Vogelstein B and Kinzler KW (cds). McGraw-Hill, New York, pp691-711, 1998.
2. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90: 809-819, 1997.
3. Malkin D: The Li-Fraumeni syndrome. In: The Genetic Basis of Human Cancer. Vogelstein B and Kinzler KW (eds). McGraw-Hill, New York, PP393-407, 1998.
4. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD and White PS: Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19: 93-101, 1997.
5. Caron H, Vansluis P, Vanhoeve M, Dekraker J, Bras J, Slater R, Mannens M, Voute PA, Wcsterveld A and Versteeg R: Allelic loss of chromosome 1p36 in neuroblastoma is of preferential maternal origin and correlates with N-myc amplification. Nat Genet 4: 187-190, 1993.
6. Caron H, van Sluis PM, Speleman F, De Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O and Versteeg R: Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 4: 535-539, 1995.
7. Brodeur GM, Seegcr RC, Barret A, Berthold F, Castleberry RP, D'Angio G, DC Bemardi B, Evans A, Favot M, Freeman AI, Haase G, Hartmann O, Hayes FA, Helson L, Kemshead L, Lampcit F, Nianc J, Ohkawa H, Philippe T, Pinkerton CR, Pritchard J, Sawada T, Siegel S, Smith El, Tsuchida Y and Voute PA: International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6: 1874-1881, 1988.
8. Brodeur GM, Pritchard J, Berthold F, Carlsen NLT, Castel V, Castlebcrry RP, Debernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, Lampert F, Lee REJ, Look AT, Pearson ADJ, Philip T, Roald B, Sawada T, Secger RC, Tsuchida Y and Voute PA: Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477, 1993.
9. Martinsson T. Sjöberg RM, Hcdborg F and Kogner P: Deletion of chromosome 1p-loci and microsatellite instability in ncuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55: 5681-5686, 1995.
10. Martinsson T, Sjöberg RM, Hallstensson K, Nordling M, Hedborg F and Kogner P: Delimitation of a critical tumor suppressor region at distal Ip in neuroblastoma tumors. Eur J Cancer 33: 1997-2001, 1997.
11. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasscau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissettc J and Weissenbach J: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152-154, 1996.
12. Ko LJ and Prives C: p53: puzzle and paradigm. Genes Dev 10: 1054-1072, 1996.
13. Nomoto S, Haruki N, Kondo M, Konishi H, Takahashi T, Takahashi T and Takahashi T: Search for mutations and examination of allclic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res 58: 1380-1383, 1998.
14. Fong C, Dracopoli NC, White PS, Merrill PT, Griffith RC, Housman DE and Brodeur GM: Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Sci. USA 86: 3753-3757, 1989.
15. Jost CA, Marin MC and Kaelin WG Jr: p73 is a human p53-related protein that can induce apoptosis. Nature 389: 191-194, 1997.